Set and setting in microdosing: an oft-overlooked principle.
Ido Hartogsohn, Rotem Petranker
Psychopharmacology December 1, 2022 DOI: 10.1007/s00213-022-06249-8 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | LSD Microdosing Psilocybin |
| Keywords | Set and setting Psychedelics hallucinogens Entheogens Microdosing sub-perceptual dosing Environment |
| Citations | 22 |
| Key points | Argues that set and setting are crucial for determining microdosing outcomes and that their omission from clinical trials may explain contradictory findings. |
Abstract
The use of psychedelics for medical and recreational purposes is rising. Contextual factors such as expectancy, intention, and sensory and social environment (set and setting) are widely recognized as moderating the effects of these substances. Nevertheless, clinical trials of microdosing - the ingestion of small, sub-hallucinogenic doses of psychedelics - rarely report their set and setting. This fact suggests that such factors are not considered important in the context of microdosing. This paper challenges this assumption and makes the case for the crucial relevance of set and setting in microdosing practice. Building on set and setting theory and placebo theory, we explain why set and setting are of crucial importance in the case of microdosing. This reasoning helps elucidate the role of set and setting in determining the outcomes of microdosing and helps explain some of the contradictory results that have emerged in microdosing research in recent years. Set and setting are important constructs to be considered especially in the context of microdosing psychedelics. By reporting set and setting, the results of microdosing research can be made more reliable and consistent.